X-136548669-G-A
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_016267.4(VGLL1):c.295G>A(p.Ala99Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000834 in 1,210,483 control chromosomes in the GnomAD database, including 1 homozygotes. There are 23 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_016267.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
VGLL1 | NM_016267.4 | c.295G>A | p.Ala99Thr | missense_variant | 3/5 | ENST00000370634.8 | NP_057351.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
VGLL1 | ENST00000370634.8 | c.295G>A | p.Ala99Thr | missense_variant | 3/5 | 1 | NM_016267.4 | ENSP00000359668 | P1 | |
VGLL1 | ENST00000440515.5 | c.190G>A | p.Ala64Thr | missense_variant | 2/4 | 3 | ENSP00000398360 | |||
VGLL1 | ENST00000456412.1 | c.41-2099G>A | intron_variant | 3 | ENSP00000388868 |
Frequencies
GnomAD3 genomes AF: 0.000517 AC: 58AN: 112205Hom.: 0 Cov.: 23 AF XY: 0.000407 AC XY: 14AN XY: 34383
GnomAD3 exomes AF: 0.000131 AC: 24AN: 183377Hom.: 0 AF XY: 0.0000884 AC XY: 6AN XY: 67849
GnomAD4 exome AF: 0.0000392 AC: 43AN: 1098225Hom.: 1 Cov.: 32 AF XY: 0.0000248 AC XY: 9AN XY: 363579
GnomAD4 genome AF: 0.000517 AC: 58AN: 112258Hom.: 0 Cov.: 23 AF XY: 0.000406 AC XY: 14AN XY: 34446
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.295G>A (p.A99T) alteration is located in exon 3 (coding exon 2) of the VGLL1 gene. This alteration results from a G to A substitution at nucleotide position 295, causing the alanine (A) at amino acid position 99 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at